Keywords:
Hybrid Imaging, Genital / Reproductive system male, Molecular imaging, PET-CT, CT, Diagnostic procedure, Cancer
Authors:
Y. O. H. Omar, E. Hamid, M. Abdel Kawi, S. Shawky, H. Samir; Cairo/EG
DOI:
10.26044/ecr2019/C-3148
References
1-Banerjee SR,
Pullambhatla M,
Byun Y,
Nimmagadda S,
Green G,
Fox JJ,
et al.
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.
J Med Chem.
2010;53(14):5333–41.
2-Afshar-Oromieh A,
Malcher A,
Eder M,
Eisenhut M,
Linhart HG,
Hadaschik BA,
et al.
PET imaging with a [68Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Eur J NuclMed Mol Imaging.
2013;40(4):486–95.
doi: 10.1007/s00259-012-2298-2.
3-Perera,
M.,
et al.
Sensitivity,
Specificity,
and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol,
2016.
70: 926